Lipid translocation across the plasma membrane of mammalian cells

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1439, Issue 3, 1999, Pages 317-330

  Bevers, Edouard M ^a   Comfurius, Paul ^a   Dekkers, David W C ^a   Zwaal, Robert F A ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Aminophospholipid translocase; Multidrug resistance protein; Phospholipid asymmetry; Scramblase; Transbilayer lipid transport

Indexed keywords

AMINOPHOSPHOLIPID; CARRIER PROTEIN; MEMBRANE LIPID; MEMBRANE PROTEIN; MULTIDRUG RESISTANCE PROTEIN; PHOSPHATIDYLINOSITOL; PHOSPHATIDYLSERINE; PHOSPHOLIPID;

ANIMAL CELL; CELL MEMBRANE; HUMAN; LIPID TRANSPORT; MAMMAL CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; SCOTT SYNDROME;

ANIMALS; APOPTOSIS; CARRIER PROTEINS; CELL LINE; CELL MEMBRANE; HUMANS; LIPID BILAYERS; LIPID METABOLISM; MEMBRANE PROTEINS; P-GLYCOPROTEIN; PHOSPHATIDYLSERINES; PHOSPHOLIPID TRANSFER PROTEINS;

MAMMALIA;

EID: 0032779519     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1388-1981(99)00110-9     Document Type: Review

References (113)

1. Zwaal R.F.A., Schroit A.J. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood. 89:1997;1121-1132.
2. Bevers E.M., Comfurius P., van Rijn J.L.M.L., Hemker H.C., Zwaal R.F.A. Generation of platelet prothrombin converting activity and the exposure of phosphatidylserine at the platelet outer surface. Eur. J. Biochem. 122:1982;429-436.
3. Bevers E.M., Comfurius P., Zwaal R.F.A. Changes in membrane phospholipid distribution during platelet activation. Biochim. Biophys. Acta. 736:1983;57-66.
4. Connor J., Bucana C., Fidler I.J., Schroit A.J. Differentiation-dependent expression of phosphatidylserine in mammalian plasma membranes: Quantitative assessment of outer leaflet lipid by prothrombinase complex formation. Proc. Natl. Acad. Sci. USA. 86:1989;3184-3188.
5. Smeets E.F., Comfurius P., Bevers E.M., Zwaal R.F.A. Contribution of different phospholipid classes to the prothrombin converting capacity of sonicated lipid vesicles. Thromb. Res. 81:1996;419-426.
6. Stuart M.C., Bevers E.M., Comfurius P., Zwaal R.F.A., Reutelingsperger C.P.M., Frederik P.M. Ultrastructural detection of surface exposed phosphatidylserine on activated blood platelets. Thromb. Haemost. 74:1995;1145-1151.
7. Tait J.F., Gibson D. Phospholipid binding of annexin V: effects of calcium and membrane phosphatidylserine content. Arch. Biochem. Biophys. 298:1992;187-191.
8. Dachary-Prigent J., Freyssinet J.-M., Pasquet J.-M., Carron J.-C., Nurden A.T. Annexin V as probe of aminophospholipid exposure and platelet membrane vesiculation: a flow cytometry study showing a role for free sulfhydryl groups. Blood. 81:1993;2554-2565.
9. Utsugi T., Schroit A.J., Connor J., Bucana C.D., Fidler I.J. Elevated expression of phosphatidylserine in the outer membrane leaflet of human tumor cells and recognition by activated human blood monocytes. Cancer Res. 51:1991;3062-3066.
10. Tilley L., Cribier S., Roelofsen B., Op den Kamp J.A.F., van Deenen L.L.M. ATP-dependent translocation of amino phospholipids across the human erythrocyte membrane. FEBS Lett. 194:1986;21-27.
11. Seigneuret M., Devaux P.F. ATP-dependent asymmetric distribution of spin-labeled phospholids in the erythrocyte membrane: relation to shape changes. Proc. Natl. Acad. Sci. USA. 81:1984;3751-3755.
12. Martin O.C., Pagano R.E. Transbilayer movement of fluorescent analogs of phosphatidylserine and phosphatidylethanolamine at the plasma membrane of cultured cells. J. Biol. Chem. 262:1987;5890-5898.
13. McIntyre J.C., Sleight R.G. Fluorescence assay for phospholipid membrane asymmetry. Biochemistry. 30:1991;11819-11827.
14. Connor J., Schroit A.J. Transbilayer movement of phosphatidylserine in erythrocytes: inhibition of transport and preferential labeling of a 31000-dalton protein by sulfhydryl reactive reagents. Biochemistry. 27:1988;848-851.
15. Williamson P., Bevers E.M., Smeets E.F., Comfurius P., Schlegel R.A., Zwaal R.F. Continuous analysis of the mechanism of activated transbilayer lipid movement in platelets. Biochemistry. 34:1995;10448-10455.
16. Connor J., Schroit A.J. Determination of lipid asymmetry in human red cells by resonance energy transfer. Biochemistry. 26:1987;5099-5105.
17. Daleke D.L., Huestis W.H. Incorporation and translocation of aminophospholipids in human erythrocytes. Biochemistry. 24:1985;5406-5416.
18. Haest C.W.M. Interactions between membrane skeleton proteins and the intrinsic domain of the erythrocyte membrane. Biochim. Biophys. Acta. 694:1982;331-352.
19. Zachowski A., Favre E., Cribier S., Herve P., Devaux P.F. Outside-inside translocation of aminophospholipids in the human erythrocyte membrane is mediated by a specific enzyme. Biochemistry. 25:1986;2585-2590.
20. Morrot G., Herve P., Zachowski A., Fellmann P., Devaux P.F. Aminophospholipid translocase of human erythrocytes: phospholipid substrate specificity and effect of cholesterol. Biochemistry. 28:1989;3456-3462.
21. Zimmerman M.L., Daleke D.L. Regulation of a candidate aminophospholipid-transporting ATPase by lipid. Biochemistry. 32:1993;12257-12263.
22. Hall M.P., Huestis W.H. Phosphatidylserine headgroup diastereomers translocate equivalently across human erythrocyte membranes. Biochim. Biophys. Acta. 1190:1994;243-247.
23. Smeets E.F., Comfurius P., Bevers E.M., Zwaal R.F. Calcium-induced transbilayer scrambling of fluorescent phospholipid analogs in platelets and erythrocytes. Biochim. Biophys. Acta. 1195:1994;281-286.
24. Bevers E.M., Wiedmer T., Comfurius P., Zhao J., Smeets E.F., Schlegel R.A., Schroit A.J., Weiss H.J., Williamson P., Zwaal R.F.A., Sims P.J. The complex of phosphatidylinositol 4,5-bisphosphate and calcium ions is not responsible for Ca(2+)-induced loss of phospholipid asymmetry in the human erythrocyte: a study in Scott syndrome, a disorder of calcium-induced phospholipid scrambling. Blood. 86:1995;1983-1991.
25. Connor J., Pak C.H., Zwaal R.F.A., Schroit A.J. Bidirectional transbilayer movement of phospholipid analogs in human red blood cells. J. Biol. Chem. 267:1992;19412-19417.
26. Beleznay Z., Zachowski A., Devaux P.F., Navazo M.P., Ott P. ATP-dependent aminophospholipid translocation in erythrocyte vesicles: stoichiometry of transport. Biochemistry. 32:1993;3146-3152.
27. Bitbol M., Fellmann P., Zachowski A., Devaux P.F. Ion regulation of phosphatidylserine and phosphatidylethanolamine outside-inside translocation in human erythrocytes. Biochim. Biophys. Acta. 904:1987;268-282.
28. 2+-induced microvesiculation and deficient expression of procoagulant activity in erythrocytes from a patient with a bleeding disorder: a study of the red blood cells of Scott syndrome. Blood. 79:1992;380-388.
29. Schroit A.J., Madsen J., Ruoho A.E. Radioiodinated, photoactivatable phosphatidylcholine and phosphatidylserine: transfer properties and differential photoreactive interaction with human erythrocyte membrane proteins. Biochemistry. 26:1987;1812-1819.
30. Schroit A.J., Bloy C., Connor J., Cartron J.-P. Involvement of Rh blood group polypeptides in the maintenance of aminophospholipid asymmetry. Biochemistry. 29:1990;10303-10306.
31. Avent N.D., Ridgwell K., Tanner M.J.A., Anstee D.J. cDNA cloning of a 30 kDa erythrocyte membrane protein associated with Rh (Rhesus)-blood-group-antigen expression. Biochem. J. 271:1990;821-825.
32. Smith R.E., Daleke D.L. Phosphatidylserine transport in Rh(Null) erythrocytes. Blood. 76:1990;1021-1027.
33. 2+-ATPase A candidate aminophospholipid translocase. FEBS Lett. 266:1990;29-32.
34. Auland M.E., Roufogalis B.D., Devaux P.F., Zachowski A. Reconstitution of ATP-dependent aminophospholipid translocation in proteoliposomes. Proc. Natl. Acad. Sci. USA. 91:1994;10938-10942.
35. A. Zachowski, D. Dolis, C. Moreau, P.F. Devaux, Reconstitution of an aminophospholipid translocase activity in proteoliposomes, Conférence Jacques Monod (CNRS) 'Lipid Diversity in Membranes and Cellular Functions', La Londe les Maures, France 1995, p. 80 (abstr.).
36. Tang X., Halleck M.S., Schlegel R.A., Williamson P. A novel subfamily of P-type ATPases with aminophospholipid transporting activity. Science. 272:1996;1495-1497.
37. Siegmund A., Grant A., Angeletti C., Malone L., Nichols J.W., Rudolph H.K. Loss of Drs2p does not abolish transfer of fluorescence-labeled phospholipids across the plasma membrane of Saccaromyces cerevisiae. J. Biol. Chem. 273:1998;34399-34405.
38. Connor J., Schroit A.J. Transbilayer movement of phosphatidylserine in nonhuman erythrocytes: evidence that the aminophospholipid transporter is a ubiquitous membrane protein. Biochemistry. 28:1989;9680-9685.
39. Pomorski T., Muller P., Zimmermann B., Burger K., Devaux P.F., Herrmann A. Transbilayer movement of fluorescent and spin-labeled phospholipids in the plasma membrane of human fibroblasts: a quantitative approach. J. Cell Sci. 109:1996;687-698.
40. Muller P., Pomorski T., Porwoli S., Tauber R., Herrmann A. Transverse movement of spin-labeled phospholipids in the plasma membrane of a hepatocytic cell line (HepG2): implications for biliary lipid secretion. Hepatology. 24:1996;1497-1503.
41. Tilly R.H.J., Senden J.M.G., Comfurius P., Bevers E.M., Zwaal R.F.A. Increased aminophospholipid translocase activity in human platelets during secretion. Biochim. Biophys. Acta. 1029:1990;188-190.
42. Bevers E.M., Tilly R.H.J., Senden J.M.G., Comfurius P., Zwaal R.F.A. Exposure of endogenous phosphatidylserine at the outer surface of stimulated platelets is reversed by restoration of amino-phospholipid translocase activity. Biochemistry. 28:1989;2382-2387.
43. Julien M., Tournier J.F., Tocanne J.F. Basic fibroblast growth factor modulates the aminophospholipid translocase activity present in the plasma membrane of bovine aortic endothelial cells. Eur. J. Biochem. 230:1995;287-297.
44. Julien M., Tocanne J.-F., Tournier J.-F. 12-O-tetradecanoylphorbol-13-acetate inhibits aminophospholipid translocase and modifies the lateral motions of fluorescent phospholipid analogs in the plasma membrane of bovine aortic endothelial cells. Exp. Cell Res. 234:1997;125-131.
45. Blumenfeld N., Zachowski A., Galacteros F., Beuzard Y., Devaux P.F. Transmembrane mobility of phospholipids in sickle erythrocytes: effect of deoxygenation on diffusion and asymmetry. Blood. 77:1991;849-854.
46. Srinivasan P.T., Basu J. Altered membrane phospholipid organization and erythrophagocytosis in E beta-thalassemia. Bioch. Biophys. Acta. 1285:1996;65-70.
47. Hanada K., Pagano R.E. A Chinese hamster ovary cell mutant defective in the non-endocytic uptake of fluorescent analogs of phosphatidylserine: isolation using a cytosol acidification protocol. J. Cell Biol. 128:1995;793-804.
48. Zhao J., Sims P.J., Wiedmer T. Production and characterization of a mutant cell line defective in aminophospholipid translocase. Biochim. Biophys. Acta. 1357:1997;57-64.
49. Bitbol M., Devaux P.F. Measurement of outward translocation of phospholipids across human erythrocyte membrane. Proc. Natl. Acad. Sci. USA. 85:1988;6783-6787.
50. Connor J., Gillum K., Schroit A.J. Maintenance of membrane lipid asymmetry in red blood cells and ghosts: effect of divalent cations and serum albumin on the transbilayer distribution of endogenous and NBD-labeled phosphatidylserine. Biochim. Biophys. Acta. 1025:1990;82-86.
51. Dekkers D.W.C., Comfurius P., Schroit A.J., Bevers E.M., Zwaal R.F.A. Transbilayer movement of NBD-labeled phospholipids in red blood cell membranes: outward-directed transport by the multidrug resistance protein 1 (MRP1). Biochemistry. 37:1998;14833-14837.
52. Kamp D., Haest C.W.M. Evidence for a role of the multidrug resistance protein (MRP) in the outward translocation of NBD-phospholipids in the erythrocyte membrane. Biochim. Biophys. Acta. 1372:1998;91-101.
53. Smit J.J., Schinkel A.H., Mol C.A., Majoor D., Mooi W.J., Jongsma A.P., Lincke C.R., Borst P. Tissue distribution of the human MDR3 P-glycoprotein. Lab. Invest. 71:1994;638-649.
54. Smit J.J., Schinkel A.H., Oude Elferink R.P., Groen A.K., Wagenaar E., van Deemter L., Mol C.A., Ottenhoff R., van der Lugt N.M., van Roon M.A., et al. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell. 75:1993;451-462.
55. Smith A.J., Timmermans-Hereijgers J.L.P.M., Roelofsen B., Wirtz K.W.A., Van Blitterswijk W.J., Smit J.J.M., Schinkel A.H., Borst P. The human MDR3 P-glycoprotein promotes translocation of phosphatidylcholine through the plasma membrane of fibroblasts from transgenic mice. FEBS Lett. 354:1994;263-266.
56. Gottesman M.M., Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem. 62:1993;385-427.
57. van Helvoort A., Smith A.J., Sprong H., Fritzsche I., Schinkel A.H., Borst P., van Meer G. MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine. Cell. 87:1996;507-517.
58. Bezombes C., Maestre N., Laurent G., Levade T., Bettaïeb A., Jaffrézou J.-P. Restoration of TNFalfa-induced ceramide generation and apoptosis in resistant human leukemia KG1a cells by the P-glycoprotein blocker PSC833. FASEB J. 12:1998;101-109.
59. Wadkins R.M., Roepe P.D. Biophysical aspects of P-glycoprotein-mediated multidrug resistance. Intern. Rev. Cytol. 171:1997;121-165.
60. Frickenhaus S., Herrmann A., Heinrich R. Compensating lipid fluxes generated by the aminophospholpid translocase. Mol. Membr. Biol. 15:1998;213-220.
61. Fadok V.A., Voelker D.R., Campbell P.A., Cohen J.J., Bratton D.L., Henson P.M. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J. Immunol. 148:1992;2207-2216.
62. Verhoven B., Schlegel R.A., Williamson P. Mechanisms of phosphatidylserine exposure, a phagocyte recognition signal, on apoptotic t lymphocytes. J. Exp. Med. 182:1995;1597-1601.
63. Bratton D.L., Fadok V.A., Richter D.A., Kailey J.M., Guthrie L.A., Henson P.M. Appearance of phosphatidylserine on apoptotic cells requires calcium-mediated nonspecific flip-flop and is enhanced by loss of the aminophospholipid translocase. J. Biol. Chem. 272:1997;26159-26165.
64. Vermes I., Haanen C., Steffensnakken H., Reutelingsperger C. A novel assay for apoptosis - flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled annexin v. J. Immunol. Methods. 184:1995;39-51.
65. Hamilton K.K., Hattori R., Esmon C.T., Sims P.J. Complement proteins C5b-9 induce vesiculation of the endothelial plasma membrane and expose catalytic surface for assembly of the prothrombinase enzyme complex. J. Biol. Chem. 265:1990;3809-3814.
66. Bombeli T., Karsan A., Tait J.F., Harlan J.M. Apoptotic vascular endothelial cells become procoagulant. Blood. 89:1997;2429-2442.
67. Chandra R., Joshi P.C., Bajpaj V.K., Gupta C.M. Membrane phospholipid organization in calcium-loaded human erythrocytes. Biochim. Biophys. Acta. 902:1987;253-262.
68. Comfurius P., Senden J.M.G., Tilly R.H.J., Schroit A.J., Bevers E.M., Zwaal R.F.A. Loss of membrane phospholipid asymmetry in platelets and red cells may be associated with calcium-induced shedding of plasma membrane and inhibition of amino-phospholipid translocase. Biochim. Biophys. Acta. 1026:1990;153-160.
69. 2+ induces transbilayer redistribution of all major phospholipids in human erythrocytes. Biochemistry. 31:1992;6355-6360.
70. Bennett M.R., Gibson D.F., Schwartz S.M., Tait J.F. Binding and phagocytosis of apoptotic vascular smooth muscle cells is mediated in part by exposure of phosphatidylserine. Circ. Res. 77:1995;1136-1142.
71. VanDeWater L., Tracy P.B., Aronson D., Mann K.G., Dvorak H.F. Tumor cell generation of thrombin via functional prothrombinase assembly. Cancer Res. 45:1985;5521-5525.
72. Rao L.V., Tait J.F., Hoang A.D. Binding of annexin V to a human ovarian carcinoma cell line (OC-2008). Contrasting effects on cell surface factor VIIa/tissue factor activity and prothrombinase activity. Thromb. Res. 67:1992;517-531.
73. 2+-ATPase inhibitors. Biochemistry. 34:1995;11625-11634.
74. Smeets E.F., Heemskerk J.W., Comfurius P., Bevers E.M., Zwaal R.F.A. Thapsigargin amplifies the platelet procoagulant response caused by thrombin. Thromb. Haemost. 70:1993;1024-1029.
75. Kuypers F.A., Lewis R.A., Hua M., Schott M.A., Discher D., Ernst J.D., Lubin B.H. Detection of altered membrane phospholipid asymmetry in subpopulations of human red blood cells using fluorescently labeled annexin v. Blood. 87:1996;1179-1187.
76. Geldwerth D., Kuypers F.A., Bütikofer P., Allary M., Lubin B.H., Devaux P.F. Transbilayer mobility and distribution of red cell phospholipids during storage. J. Clin. Invest. 92:1993;308-314.
77. 2+-induced phospholipid redistribution in the human erythrocyte membrane. J. Biol. Chem. 269:1994;6347-6354.
78. Sims P.J., Wiedmer T., Esmon C.T., Weiss H.J., Shattil S.J. Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott syndrome: an isolated defect in platelet procoagulant activity. J. Biol. Chem. 264:1989;17049-17057.
79. Wiedmer T., Shattil S.J., Cunningham M., Sims P.J. Role of calcium and calpain in complement-induced vesiculation of the platelet plasma membrane and in the exposure of the platelet factor Va receptor. Biochemistry. 29:1990;623-632.
80. Fox J.E.B., Austin C.D., Reynolds C.C., Steffen P.K. Evidence that agonist-induced activation of calpain causes the shedding of procoagulant-containing microvesicles from the membrane of aggregating platelets. J. Biol. Chem. 266:1991;13289-13295.
81. Bassé F., Gaffet P., Rendu F., Bienvenüe A. Translocation of spin-labeled phospholipids through plasma membrane during thrombin- and ionophore A23187-induced platelet activition. Biochemistry. 32:1993;2337-2344.
82. Bucki R., Bachelot-Loza C., Zachowski A., Giraud F., Sulpice J.-C. Calcium induces phospholipid distribution and microvesicle release in human erythrocyte membranes by independent pathways. Biochemistry. 37:1998;15383-15391.
83. E.F. Smeets, Thesis, University of Maastricht, The Netherlands, 1996.
84. Williamson P., Algarin L., Bateman J., Choe H.-R., Schlegel R.A. Phospholipid asymmetry in human erythrocyte ghosts. J. Cell. Physiol. 123:1985;209-214.
85. Martin D.W., Jesty J. Calcium stimulation of procoagulant activity in human erythrocytes - ATP dependence and the effects of modifiers of stimulation and recovery. J. Biol. Chem. 270:1995;10468-10474.
86. 2+-induced tyrosine phosphorylation and defective lipid scrambling in erythrocytes from a patient with Scott Syndrome: a study using an inhibitor for scramblase that mimics the defect in Scott syndrome. Blood. 91:1998;2133-2138.
87. Comfurius P., Williamson P., Smeets E.F., Schlegel R.A., Bevers E.M., Zwaal R.F. Reconstitution of phospholipid scramblase activity from human blood platelets. Biochemistry. 35:1996;7631-7634.
88. 2+-dependent transbilayer movement of phospholipid. J. Biol. Chem. 271:1996;17205-17210.
89. 2+-dependent transbilayer migration of membrane phospholipids. J. Clin. Invest. 99:1997;2232-2238.
90. Zhou Q.S., Zhao J., Stout J.G., Luhm R.A., Wiedmer T., Sims P.J. Molecular cloning of human plasma membrane phospholipid scramblase - a protein mediating transbilayer movement of plasma membrane phospholipids. J. Biol. Chem. 272:1997;18240-18244.
91. 2+-accelerated transbilayer movement of membrane phospholipids. Biochemistry. 37:1998;2356-2360.
92. Zhou Q., Sims P.J., Wiedmer T. Expression of proteins controlling transbilayer movement of plasma membrane phospholipids in the B-lymphocytes from a patient with Scott syndrome. Blood. 92:1998;1707-1712.
93. 2+-activated transbilayer movement of membrane phospholipids. Biochemistry. 37:1998;6361-6366.
94. Zhao J., Zhou Q.S., Wiedmer T., Sims P.J. Level of expression of phospholipid scramblase regulates induced movement of phosphatidylserine to the cell surface. J. Biol. Chem. 273:1998;6603-6606.
95. 2+ binding site. Biochemistry. 37:1998;14860-14866.
96. Kasukabe T., Kobayashi H., Kaneko Y., Okabe-Kado J., Honma Y. Identity of human normal counterpart (MmTRA1b) of mouse leukemogenesis-associated gene (MmTRA1a) product as plasma membrane scramblase and chromosome mapping of the human MmTRA1b/phospholipid scramblase gene. Biochem. Biophys. Res. Commun. 249:1998;449-455.
97. Chang C.-P., Zhao J., Wiedmer T., Sims P.J. Contribution of platelet microparticle formation and granule secretion to the transmembrane migration of phosphatidylserine. J. Biol. Chem. 268:(10):1993;7171-7178.
98. Weiss H.J. Scott syndrome: a disorder of platelet coagulant activity. Semin. Hematol. 31:1994;312-319.
99. Toti F., Satta N., Fressinaud E., Meyer D., Freyssinet J.M. Scott syndrome, characterized by impaired transmembrane migration of procoagulant phosphatidylserine and hemorrhagic complications, is an inherited disorder. Blood. 87:1996;1409-1415.
100. Weiss H.J., Lages B. Family studies in Scott syndrome. Blood. 90:1997;475-476.
101. Weiss H.J., Vicic W.J., Lages B.A., Rogers J. Isolated deficiency of platelet procoagulant activity. Am. J. Med. 67:1979;206-213.
102. Rosing J., Bevers E.M., Comfurius P., Hemker H.C., Dieijen van G., Weiss H.J., Zwaal R.F.A. Impaired factor X- and prothrombin activation associated with decreased phospholipid exposure in platelets from a patient with a bleeding disorder. Blood. 65:1985;1557-1561.
103. Kojima H., Newtonnash D., Weiss H.J., Zhao J., Sims P.J., Wiedmer T. Production and characterization of transformed B-lymphocytes expressing the membrane defect of Scott syndrome. J. Clin. Invest. 94:1994;2237-2244.
104. Toti F., Schindler V., Riou J.-F., Lombard-Platet G., Fressinaud E., Meyer D., Uzan A., Le Pecq J.-B., Mandel J.-L., Freyssinet J.-M. Another link between phospholipid transmembrane migration and ABC transporter gene family, inferred from a rare inherited disorder of phosphatidylserine externalization. Biochem. Biophys. Res. Commun. 241:1997;548-552.
105. Janel N., Leroy C., Laude I., Toti F., Fressinaud E., Meyer D., Freyssinet J.-M., Kerbiriou-Nabias D. Assessment of the expression of candidate human plasma membrane phospholipid scramblase in Scott syndrome cells. Thromb. Haemostas. 81:1998;322.
106. Dachary-Prigent J., Pasquet J.M., Fressinaud E., Toti F., Freyssinet J.M., Nurden A.T. Aminophospholipid exposure, microvesiculation and abnormal protein tyrosine phosphorylation in the platelets of a patient with Scott syndrome: a study using physiologic agonists and local anaesthetics. Br. J. Haematol. 99:1997;959-967.
107. Tans G., Rosing J., Thomassen M.C.L.G.D., Heeb M.J., Zwaal R.F.A., Griffin J.H. Comparison of anticoagulant and procoagulant properties of stimulated platelets and platelet-derived microparticles. Blood. 77:1991;2641-2648.
108. Diaz C., Schroit A.J. Role of translocases in the generation of phosphatidylserine asymmetry. J. Membr. Biol. 151:1996;1-9.
109. Hampton M.B., Vanags D.M., Pörn-Ares M.I., Orrenius S. Involvement of extracellular calcium in phosphatidylserine exposure during apoptosis. FEBS Lett. 399:1996;277-282.
110. Meisenholder G.W., Martin S.J., Green D.R., Nordberg J., Babior B.M., Gottlieb R.A. Events in apoptosis. Acidification is downstream of protease activation and BCL-2 protection. J. Biol. Chem. 271:1996;16260-16262.
111. Martin S.J., Reutelingsperger C.P.M., Mcgahon A.J., Rader J.A., Vanschie R.C.A.A., Laface D.M., Green D.R. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of bcl-2 and abl. J. Exp. Med. 182:1995;1545-1556.
112. Martin S.J., Finucane D.M., Amarante Mendes G.P., O'Brien G.A., Green D.R. Phosphatidylserine externalization during CD95-induced apoptosis of cells and cytoplasts requires ICE/CED-3 protease activity. J. Biol. Chem. 271:1996;28753-28756.
113. Vanags D.M., Porn Ares M.I., Coppola S., Burgess D.H., Orrenius S. Protease involvement in fodrin cleavage and phosphatidylserine exposure in apoptosis. J. Biol. Chem. 271:1996;31075-31085.